Clinical Researcher: Myths and Realities of Placebo Response - A 21st Century Prescription

June 29, 2017

Randomized, placebo-controlled clinical trials are the most challenging and complex aspect of development and commercialization of new drugs. The costs of conducting trials have continued to increase, trending ever upward. 

One important indicator of clinical research quality is the extent to which trials detect effect signals (i.e., do trials separate experimental treatments from placebo). Rates of placebo response across multiple therapeutic areas are now historically high and progressively increasing. 

In this article, we review three of the commonly shared (but likely false) ideas that clinical researchers have about placebo response. 

Previous Video
How Optimized Training Can Lead to a Positive Clinical Trial
How Optimized Training Can Lead to a Positive Clinical Trial

Next Flipbook
Improving Subject Selection and Endpoint Management in Alzheimer's Trials
Improving Subject Selection and Endpoint Management in Alzheimer's Trials